Dr. Vicky W. Yang, MD

Dr. Yang practices at Atherton Endoscopy Center - HOPD in Atherton, California.

Dr. Yang's NPI, 1710063334, was assigned on October 27, 2006. Dr. Yang graduated from Feinberg School of Medicine in 1993. Dr. Yang holds California license G805360.

Dr. Yang's primary practice is Atherton Endoscopy Center - HOPD, at 3351 El Camino Real, Atherton, CA 94027.

Dr. Yang's primary practice is Atherton Endoscopy Center - HOPD in Atherton, California. Dr. Yang is also affiliated with El Camino Health - Mountain View Hospital. The medical group on file is UCSF Clinical Integrated Partners. Dmand AI also links Dr. Yang to 1 more hospital, 4 medical groups, 3 group practices and clinics and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yang practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Yang's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Yang is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Yang is licensed in California.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), colonoscopy, fatty liver, gastroduodenitis and gastroenteritis among the conditions Dr. Yang treats.

CMS data shows 631 Medicare services from Dr. Yang across 9 procedure codes in 2024, for 385 Medicare patients. Medicare paid $83,108 for them.

CMS counts 385 Medicare patients who saw Dr. Yang in 2024. The largest group is 65 to 74, with 217 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.70, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Yang's median patient age at 57, with 65% women.

In 2024, Dr. Yang wrote 455 Medicare Part D claims for 210 patients. 75% of them were for generic drugs. CMS names the drug for 367 of them, across 9 drugs with 11 or more claims each, at $219,136 in total drug cost. In 2023, CMS named 402 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Yang for performance year 2024, reported as part of a group. Dr. Yang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yang as offering telehealth. CMS counts 110 procedures of colonoscopy by Dr. Yang, more than 82% of the clinicians it reports for that procedure.

CMS Open Payments shows 533 general payments to Dr. Yang from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Gilead Sciences, Inc. paid the most, $5,079.

Dmand AI lists 1 award for Dr. Yang, most recently CMS Stage 1 2012 in 2012.

Dr. Yang graduated from Feinberg School of Medicine in 1993.

Dr. Yang is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.